Literature DB >> 11225690

Evolution of depressive symptoms in human immunodeficiency virus-infected patients entering primary care.

J B Savetsky1, L M Sullivan, J Clarke, M D Stein, J H Samet.   

Abstract

Our purpose was to examine among HIV-infected patients a) characteristics associated with depressive symptoms at initial primary care presentation and b) factors associated with improvement in depressive symptoms. We interviewed HIV-infected patients at initial presentation and reassessed them 6 months later. At baseline and follow-up, we collected data on depressive symptoms (CES-D) and other characteristics. Using multiple linear regression, we examined associations between CES-D score and baseline variables. We used multiple logistic regression to examine factors associated with improvement in depressive symptoms. Seventy-one percent of the baseline sample (N = 203) scored above the threshold considered indicative of depression. At 6 months, 36% of the subjects who were followed improved in depressive symptoms. Higher baseline CES-D scores, improvements in HIV-related symptoms, and joining a support group were associated with improvement. Depressive symptoms in this urban HIV-infected population were highly prevalent. It is essential to screen, identify, and treat depression among patients entering care for HIV disease. Encouragement in joining support groups is a reasonable component of a strategy for addressing this common condition.

Entities:  

Mesh:

Year:  2001        PMID: 11225690     DOI: 10.1097/00005053-200102000-00002

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  9 in total

1.  Association of long-term patterns of depressive symptoms and attention/executive function among older men with and without human immunodeficiency virus.

Authors:  Nicole M Armstrong; Pamela J Surkan; Glenn J Treisman; Ned C Sacktor; Michael R Irwin; Linda A Teplin; Ron Stall; Eileen M Martin; James T Becker; Cynthia Munro; Andrew J Levine; Lisa P Jacobson; Alison G Abraham
Journal:  J Neurovirol       Date:  2017-04-20       Impact factor: 2.643

Review 2.  Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults.

Authors:  Stephanie M Matt; Peter J Gaskill
Journal:  Brain Res       Date:  2019-08-21       Impact factor: 3.252

3.  Assessing the effect of Measurement-Based Care depression treatment on HIV medication adherence and health outcomes: rationale and design of the SLAM DUNC Study.

Authors:  Brian W Pence; Bradley N Gaynes; Quinn Williams; Riddhi Modi; Julie Adams; E Byrd Quinlivan; Amy Heine; Nathan Thielman; Michael J Mugavero
Journal:  Contemp Clin Trials       Date:  2012-04-20       Impact factor: 2.226

4.  Effect of dysthymia on receipt of HAART by minority HIV-infected women.

Authors:  Barbara J Turner; John A Fleishman
Journal:  J Gen Intern Med       Date:  2006-12       Impact factor: 5.128

5.  Persons newly diagnosed with HIV infection are at high risk for depression and poor linkage to care: results from the Steps Study.

Authors:  Ramona Bhatia; Christine Hartman; Michael A Kallen; James Graham; Thomas P Giordano
Journal:  AIDS Behav       Date:  2011-08

6.  Quality of life of HIV-infected patients: psychometric properties and validation of the German version of the MQOL-HIV.

Authors:  G Kemmler; B Schmied; A Shetty-Lee; R Zangerle; H Hinterhuber; G Schüssler; B Mumelter
Journal:  Qual Life Res       Date:  2003-12       Impact factor: 4.147

7.  Reasons for ART non-adherence in the Deep South: adherence needs of a sample of HIV-positive patients in Mississippi.

Authors:  K Rivet Amico; D J Konkle-Parker; D H Cornman; W D Barta; R Ferrer; W E Norton; C Trayling; P Shuper; J D Fisher; W A Fisher
Journal:  AIDS Care       Date:  2007-11

8.  Chronic SSRI treatment reverses HIV-1 protein-mediated synaptodendritic damage.

Authors:  Adam R Denton; Charles F Mactutus; Almeera U Lateef; Steven B Harrod; Rosemarie M Booze
Journal:  J Neurovirol       Date:  2021-05-18       Impact factor: 3.739

9.  Prevalence and correlates of depressive symptoms in HIV-positive patients: a cross-sectional study among newly diagnosed patients in Yaoundé, Cameroon.

Authors:  Rodrigue Minya L'akoa; Jean Jacques N Noubiap; Yixin Fang; Félicien Enyime Ntone; Christopher Kuaban
Journal:  BMC Psychiatry       Date:  2013-09-22       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.